Business
Siemens Healthineers AG: Release of a capital market information
Siemens Healthineers AG: Release of a capital market
About this update from Siemens Healthineers Ag
[{"type":"text","content":"\n\n\nEQS Post-admission Duties announcement: Siemens Healthineers AG\n\n\n / Disclosure pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052\n\n\n\n\n\nSiemens Healthineers AG: Release of a capital market information \n\n\n\n\n\n\n26.05.2026 / 18:00 CET/CEST\n\n\nDissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.\n\nThe issuer is solely responsible for the content of this announcement.Disclosure pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052\n\nThe share buyback resolved on 21 May 2026 by the Managing Board of Siemens Healthineers AG (hereinafter also referred to as \"Company\") will commence on 1 June 2026. In the time period until 29 January 2027, treasury shares of the Company with a maximum value of EUR 230,000,000.00 (excluding incidental transaction charges) shall be acquired, in total, however, no more than 14,000,000 no-par-value shares. The acquired shares will be used in connection with share-based remuneration programs and, respectively, employee share programs of the Company or affiliated entities of the Company and will be delivered to persons who have or had an employment relationship with the Company or an affiliated entity of the Company, as well as to board members of affiliated entities of the Company. In addition, subject to a decision by the Supervisory Board, the acquired shares may be used to service obligations or rights to acquire shares in the Company agreed with members of the Managing Board of the Company in the context of their compensation. To the extent that the acquired shares are not required for such purposes, they may be used for other legally permissible purposes. The Managing Board thereby exercises the authorization granted by the Annual Shareholders' Meeting of Siemens Healthineers AG on 5 February 2026 to acquire treasury shares pursuant to Section 71 para. 1 no. 8 of the German Stock Corporation Act (Aktiengesetz, AktG).\n\nA credit institution is mandated...